Skip to content

JLS Pharma: what changed

BE 0771.655.091NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€71,664
2024 · €7,075+€64,589
Equity
€29,426
2024 · €97,762-€68,336
Cash
€50,531
2024 · €83,876-€33,345
Balance sheet total
€232,526
2024 · €218,052+€14,474

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€39,097

    up €39,097 (+72.4%), from €53,972 to €93,069

    of which Other amounts receivable: +€20,473

  • Cash -€33,345

    down €33,345 (-39.8%), from €83,876 to €50,531

    mainly Contributions, distributions and other (-€140,000) and Receivables within one year (-€39,097)

  • Stocks and contracts +€8,627

    up €8,627 (+12.4%), from €69,510 to €78,137

  • Tangible fixed assets +€5,219

    up €5,219 (+7,920%), from €66 to €5,285

    of which Plant, machinery and equipment: +€5,285

  • Deferred charges and accrued income -€4,251

    down €4,251 (-87.1%), from €4,881 to €629

Equity and liabilities
  • Other debts +€70,000

    first reported in 2025, at €70,000

  • Reserves -€68,336

    down €68,336 (-93.9%), from €72,762 to €4,426

  • Tax, wage and social debts +€15,806

    up €15,806 (+58.4%), from €27,076 to €42,882

    of which Taxes: +€14,613

  • Trade debts -€3,765

    down €3,765 (-5.8%), from €64,536 to €60,771

    of which Suppliers: -€11,176

Income statement
  • Gross operating margin +€94,673

    up €94,673 (+47.2%), from €200,413 to €295,086

  • Taxes +€21,936

    up €21,936 (+1,187%), from €1,848 to €23,784

  • Staff costs +€8,816

    up €8,816 (+4.7%), from €189,321 to €198,138

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €7,075
Gross operating margin +€94,673
Staff costs -€8,816
Depreciation +€314
Other operating charges -€65
Financial income +€721
Financial charges -€302
Taxes -€21,936
Result 2025 €71,664
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€112,023
Investment -€5,368
Financing -€140,000
Cash 2024 €83,876
Net result for the year +€71,664
Depreciation +€1,021
Stocks and contracts -€8,627
Receivables within one year -€39,097
Deferred charges and accrued income +€4,251
Trade debts -€3,765
Tax, wage and social debts +€15,806
Other debts +€70,000
Accrued charges and deferred income +€769
Investment in fixed assets (net) -€5,368
Contributions, distributions and other -€140,000
Cash 2025 €50,531
brings cash intakes cash out
Every line side by side 46 lines
Line Code 2024 2025 Change %
Total assets 20/58 €218,052 €232,526 +€14,474 +6.6%
Formation expenses 20 €0 €0 =
Fixed assets 21/28 €5,813 €10,159 +€4,346 +74.8%
Intangible fixed assets 21 €5,747 €4,874 -€873 -15.2%
Tangible fixed assets 22/27 €66 €5,285 +€5,219 +7,920%
Plant, machinery and equipment 23 - €5,285 +€5,285
Furniture and vehicles 24 €66 €0 -€66 -100%
Assets under construction and advance payments 27 €0 €0 =
Current assets 29/58 €212,239 €222,367 +€10,128 +4.8%
Stocks and contracts in progress 3 €69,510 €78,137 +€8,627 +12.4%
Stocks 30/36 €69,510 €78,137 +€8,627 +12.4%
Amounts receivable within one year 40/41 €53,972 €93,069 +€39,097 +72.4%
Trade receivables 40 €48,646 €67,270 +€18,624 +38.3%
Other amounts receivable 41 €5,326 €25,799 +€20,473 +384%
Cash at bank and in hand 54/58 €83,876 €50,531 -€33,345 -39.8%
Deferred charges and accrued income 490/1 €4,881 €629 -€4,251 -87.1%
Total equity and liabilities 10/49 €218,052 €232,526 +€14,474 +6.6%
Equity 10/15 €97,762 €29,426 -€68,336 -69.9%
Contributions 10/11 €25,000 €25,000 = 0.0%
Reserves 13 €72,762 €4,426 -€68,336 -93.9%
Distributable reserves 133 €72,762 €4,426 -€68,336 -93.9%
Amounts payable 17/49 €120,290 €203,100 +€82,810 +68.8%
Amounts payable after more than one year 17 €28,678 €28,678 = 0.0%
Other amounts payable 178/9 €28,678 €28,678 = 0.0%
Amounts payable within one year 42/48 €91,612 €173,654 +€82,042 +89.6%
Trade debts 44 €64,536 €60,771 -€3,765 -5.8%
Suppliers 440/4 €64,536 €53,361 -€11,176 -17.3%
Bills of exchange payable 441 - €7,411 +€7,411
Taxes, remuneration and social security 45 €27,076 €42,882 +€15,806 +58.4%
Taxes 450/3 €2,589 €17,202 +€14,613 +564%
Remuneration and social security 454/9 €24,487 €25,681 +€1,194 +4.9%
Other amounts payable 47/48 - €70,000 +€70,000
Accrued charges and deferred income 492/3 €0 €769 +€769
Remuneration, social security and pensions 62 €189,321 €198,138 +€8,816 +4.7%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €1,335 €1,021 -€314 -23.5%
Other operating charges 640/8 €244 €309 +€65 +26.6%
Gross operating margin 9900 €200,413 €295,086 +€94,673 +47.2%
Operating profit (loss) 9901 €9,513 €95,618 +€86,106 +905%
Financial income 75/76B €78 €799 +€721 +929%
Recurring financial income 75 €78 €799 +€721 +929%
Financial charges 65/66B €667 €970 +€302 +45.3%
Recurring financial charges 65 €667 €970 +€302 +45.3%
Profit (loss) for the period before taxes 9903 €8,923 €95,448 +€86,525 +970%
Income taxes 67/77 €1,848 €23,784 +€21,936 +1,187%
Profit (loss) for the period 9904 €7,075 €71,664 +€64,589 +913%
Profit (loss) for the period to be appropriated 9905 €7,075 €71,664 +€64,589 +913%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€123,694 to €168,261

Midpoint €142,263 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €24,552
Capitalised earnings €222,836 to €311,970
Indication €123,694 to €168,261

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€29,426
Intangible fixed assets (21)
-€4,874
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€24,552

Capitalised earnings

net result for the year (9904)
2025
€71,664
2024
€7,075
2023
€14,854
2022
€50,834
Average result
€31,197
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€222,836 / €259,975 / €311,970

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 16 November 2026 via checked.be.